Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiquan Xue

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Medcomm|June 17, 2024
Natural killer cells in cancer immunotherapyDanRu Wang, LingYun Dou, LiHao Sui, et al.
Pharmacological Research|October 22, 2022
Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancerMingyan Huang, Jianhua Luo, Xinpei Ji, et al.
Oncotarget|February 1, 2018
CXCR2<sup>+</sup> MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustionHa Zhu, Yan Gu, Yiquan Xue, et al.
Biomarker Research|August 22, 2024
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyondJialin Lu, Yuqing Ma, Qiuxin Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2014
IFN-γ primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473bCong Wu, Yiquan Xue, Pin Wang, et al.
Cell Research|June 20, 2019
Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylationYumei Zhou, Mengxuan Li, Yiquan Xue, et al.
Science (New York, N.Y.)|April 19, 2014
The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiationPin Wang, Yiquan Xue, Yanmei Han, et al.
Nature Communications|June 10, 2017
Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunityMeng Xia, Juan Liu, Shuxun Liu, et al.
Nature Cancer|October 28, 2025
SCRN1 confers hepatocellular carcinoma resistance to ferroptosis by stabilizing GPX4 via STK38-mediated phosphorylationYijie Tao, Shulei Yin, Kai Wei, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medcomm|June 17, 2024
Natural killer cells in cancer immunotherapyDanRu Wang, LingYun Dou, LiHao Sui, et al.
Pharmacological Research|October 22, 2022
Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancerMingyan Huang, Jianhua Luo, Xinpei Ji, et al.
Oncotarget|February 1, 2018
CXCR2<sup>+</sup> MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustionHa Zhu, Yan Gu, Yiquan Xue, et al.
Biomarker Research|August 22, 2024
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyondJialin Lu, Yuqing Ma, Qiuxin Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2014
IFN-γ primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473bCong Wu, Yiquan Xue, Pin Wang, et al.
Cell Research|June 20, 2019
Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylationYumei Zhou, Mengxuan Li, Yiquan Xue, et al.
Science (New York, N.Y.)|April 19, 2014
The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiationPin Wang, Yiquan Xue, Yanmei Han, et al.
Nature Communications|June 10, 2017
Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunityMeng Xia, Juan Liu, Shuxun Liu, et al.
Nature Cancer|October 28, 2025
SCRN1 confers hepatocellular carcinoma resistance to ferroptosis by stabilizing GPX4 via STK38-mediated phosphorylationYijie Tao, Shulei Yin, Kai Wei, et al.
Pageof 1